SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?


To: tommysdad who wrote (328)4/23/1999 8:01:00 AM
From: Dr. John M. de Castro  Respond to of 399
 
tommysdad, nice thoughts. I'd add that IMHO ARQL has acquired a vast amount of information on molecular interaction with a variety of targets. They are developing (look at their job listings) the bioinformatics capability to deal with all this information. This could be of great value to pharmas in and of itself. Knowledge of what kinds of molecules interact with what kinds of targets can greatly accelerate the process of identifying leads.

John de C